Nxera Pharma Co., Ltd. (TYO:4565)
Japan · Delayed Price · Currency is JPY 1,212.00
-30.00 (-2.42%)
May 12, 2026, 3:30 PM JST
Nxera Pharma Market Cap
Nxera Pharma has a market cap or net worth of 111.18 billion as of May 12, 2026. Its market cap has increased by 70.58% in one year.
Market Cap
111.18B
Enterprise Value
155.41B
Revenue
34.23B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,212.00
Market Cap Chart
Since July 29, 2004, Nxera Pharma's market cap has increased from 38.40B to 111.18B, an increase of 189.55%. That is a compound annual growth rate of 5.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2026 | 111.18B | 48.56% |
| Dec 30, 2025 | 74.84B | -20.57% |
| Dec 30, 2024 | 94.22B | -25.87% |
| Dec 29, 2023 | 127.10B | -27.43% |
| Dec 30, 2022 | 175.15B | 12.85% |
| Dec 30, 2021 | 155.21B | 7.00% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SanBio Company | 176.22B |
| GNI Group | 166.09B |
| PeptiDream | 148.08B |
| Takara Bio | 137.51B |
| Oncolys BioPharma | 85.45B |
| Cuorips | 52.44B |
| Healios K.K. | 46.44B |
| Japan Tissue Engineering | 23.88B |